CCL2 and obesity disorder: One possible explanation is that the adipose tissue itself leads to a systemic pro-inflammatory state by promoting the secretion and release of pro-inflammatory mediators such as IL-6, IL-1β, TNF-α, leptin, and MCP-1, so that obesity per se is a risk factor for the development of EDy [58].